Expression of the β-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue
- 1 August 2000
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 108 (1-2), 192-200
- https://doi.org/10.1016/s0165-5728(00)00274-5
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Expression of the interferon‐γ‐inducible chemokines IP‐10 and Mig and their receptor, CXCR3, in multiple sclerosis lesionsNeuropathology and Applied Neurobiology, 2000
- Expression of MCP-1 by Reactive Astrocytes in Demyelinating Multiple Sclerosis LesionsThe American Journal of Pathology, 1999
- Immunohistochemical Study of the β-Chemokine Receptors CCR3 and CCR5 and Their Ligands in Normal and Alzheimer's Disease BrainsThe American Journal of Pathology, 1998
- Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesionsJournal of Neuroimmunology, 1998
- The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.Journal of Clinical Investigation, 1998
- Etiology and Pathogenesis of Multiple SclerosisSeminars in Neurology, 1998
- Full length articleDevelopmental Brain Research, 1997
- Identification of a major co-receptor for primary isolates of HIV-1Nature, 1996
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesCell, 1996
- Inflammation in the nervous systemCurrent Opinion in Neurobiology, 1995